✦ LIBER ✦

Teratogen update: Fetal effects of indomethacin administration during pregnancy

✍ Scribed by Norton, Mary E.

Publisher: John Wiley and Sons
Year: 1997
Tongue: English
Weight: 90 KB
Volume: 56
Category: Article
ISSN: 0040-3709
DOI: 10.1002/(sici)1096-9926(199710)56:4<282::aid-tera7>3.0.co;2-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Fetal cardiac effects of maternal hyperg

Fetal cardiac effects of maternal hyperglycemia during pregnancy

✍ Niamh Corrigan; Derek P. Brazil; Fionnuala McAuliffe 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 98 KB 👁 1 views

## Abstract Maternal diabetes mellitus is associated with increased teratogenesis, which can occur in pregestational type 1 and type 2 diabetes. Cardiac defects and with neural tube defects are the most common malformations observed in fetuses of pregestational diabetic mothers. The exact mechanism

Teratogen update: Reproductive risks of

Teratogen update: Reproductive risks of leflunomide (Arava?); A pyrimidine synthesis inhibitor: counseling women taking leflunomide before or during pregnancy and men taking leflunomide who are contemplating fathering a child

✍ Brent, Robert L. 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 62 KB

Arava™ (leflunomide) is a pyrimidine synthesis inhibitor used in the treatment of active rheumatoid arthritis (RA). The chemical name for leflunomide is N-(4Ј-trifluoromethylphenyl)-5-methylisoxazole-4-carboxamide. Because the drug has been successful in the treatment of rheumatoid arthritis, it is